Schedule
- Noon-1:00 PM
- 11th Floor Mid Campus Center, North Conference Room (in person)
- Zoom (virtual)
Archive by Academic year
| Date | Speaker | Title |
|---|---|---|
| Aug 2, 2023 | Emily Podany | BREAST CANCER Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer PubMed |
| Interrupting Endocrine Therapy to Attempt Pregnancy After Breast Cancer PubMed | ||
| Aug 9, 2023 | Christine Auberle | LUNG CANCER Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer PubMed |
| Brendan Knapp | Overall Survival With Osimertinib in Resected EGFR-Mutated NSCLC PubMed | |
| Sep 1, 2023 | GI CANCER | |
| Apr 11,2024 | Rigoberto De Jesus Pizarro Joshua Siner | Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma PubMed Oral decitabine and cedazuridine plus venetoclax for elderly AML PubMed |
| Date | Speaker | Title |
|---|---|---|
| Jan 12, 2023 | Fahrettin Covut | BREAST CANCER Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer PubMed |
| Emily Podany | Event-Free Survival With Pembrolizumab in Early Triple-Negative Breast Cancer PubMed | |
| Mar 30, 2023 | Christine Auberle | CUTANEOUS / SOFT TISSUE CANCERS Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134 PubMed |
| Nicole Foley | Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma PubMed | |
| Apr 12, 2023 | Bindiya Patel | LUNG CANCER Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRAS G12C Mutation PubMed |
| Joshua Siner | Neoadjuvant Nivolumab Plus Chemotherapy in Resectable Lung Cancer PubMed | |
| Apr 27, 2023 | Wilbur Song | GASTROINTESTINAL CANCER PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer PubMed |
| Giulia Petrone | Molecular Residual Disease and Efficacy of Adjuvant Chemotherapy in Patients With Colorectal Cancer PubMed | |
| May 18, 2023 | Giordano Cittolin-Santos | GYN MALIGNANCIES / GENITOURINARY CANCERS Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer PubMed |
| Jesse Zaretsky | Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up PubMed | |
| May 25, 2023 | Stefan Tarnawsky | CENTRAL / PERIPHERAL NERVOUS SYSTEM CANCER Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma PubMed |
| Rigoberto De Jesus Pizarro | DNA Methylation Subclasses Predict the Benefit From Gross Total Tumor Resection in IDH-Wildtype Glioblastoma Patients PubMed | |
| Jun 13, 2023 | Andrew Young | CLASSICAL HEMATOLOGY Familial Clonal Hematopoiesis in a Long Telomere Syndrome PubMed |
| Oladipo Cole | Direct Oral Anticoagulants Vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial PubMed | |
| Jun 20, 2023 | Michael Slade | MYELOMA / LEUKEMIA Intensive Chemotherapy With or Without Gemtuzumab Ozogamicin in Patients With NPM1-Mutated Acute Myeloid Leukaemia (AMLSG 09-09): A Randomised, Open-Label, Multicentre, Phase 3 Trial PubMed |
| Michael Kramer | Cilta-Cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma PubMed | |
| Jun 29, 2023 | Jared Cohen | THROMBOSIS & BLEEDING DISORDERS / LYMPHOMA Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems PubMed |
| Raya Saba | Concurrent Pembrolizumab With AVD for Untreated Classic Hodgkin Lymphoma PubMed |
| Date | Speaker | Title |
|---|---|---|
| Jan 13, 2022 | Jing Xi | BREAST CANCER Adjuvant Abemaciclib Combined With Endocrine Therapy for High-Risk Early Breast Cancer: Updated Efficacy and Ki-67 Analysis From the monarchE Study PubMed |
| Whitney Hensing | Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR1, HER22, Node-Positive, High-Risk, Early Breast Cancer (monarchE) PubMed | |
| – – | Trastuzumab Deruxtecan (T-DXd) Vs Trastuzumab Emtansine (T-DM1) in Patients (Pts) With HER2+ Metastatic Breast Cancer (MBC): Results of the Randomized Phase III DESTINY-Breast03 Study view pdf | |
| Mar 31, 2022 | Raya Saba | CUTANEOUS/SOFT TISSUE CANCERS Overall Survival Benefit With Tebentafusp in Metastatic Uveal Melanoma PubMed |
| Giordano Cittolin-Santos | Relatlimab and Nivolumab Versus Nivolumab in Untreated Advanced Melanoma PubMed | |
| Apr 13, 2022 | Jared Cohen | LUNG CANCER Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer PubMed |
| Alice Zhou | Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial PubMed | |
| Apr 28, 2022 | Michael Kramer | GASTROINTESTINAL CANCER Temozolomide Followed by CombinationWith Low-Dose Ipilimumab and Nivolumabin Patients With Microsatellite-Stable,O6-Methylguanine–DNA Methyltransferase–Silenced Metastatic Colorectal Cancer: TheMAYA Trial PubMed |
| Michael Iglesia | Trastuzumab Deruxtecan (DS-8201) in Patients With HER2-Expressing Metastatic Colorectal Cancer (DESTINY-CRC01): A Multicentre, Open-Label, Phase 2 Trial PubMed | |
| May 12, 2022 | Oladipo Cole | GENITOURINARY CANCERS Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma PubMed |
| Michael Slade | Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer PubMed | |
| May 19, 2022 | Andrew Young | GYN ONC MALIGNANCIES Lenvatinib Plus Pembrolizumab for Advanced Endometrial Cancer PubMed |
| Bindiya Patel | Inherent Mosaicism and Extensive Mutation of Human Placentas PubMed | |
| May 26, 2022 | Jesse Zaretsky | CENTRAL/PERIPHERAL NERVOUS SYSTEM CANCER CAR T Cell Killing Requires the IFNγR Pathway in Solid but Not Liquid Tumours PubMed |
| Jun 14, 2022 | Joshua Siner | CLASSICAL HEMATOLOGY Mitapivat Versus Placebo for Pyruvate Kinase Deficiency PubMed |
| Rigoberto De Jesus Pizarro | Lupus Anticoagulant Test Persistence Over Time and Its Associations With Future Thrombotic Events PubMed | |
| Jun 22, 2022 | Dilan Patel | MYELOMA/LEUKEMIA Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia PubMed |
| Fahrettin Covut | Triplet Therapy, Transplantation, and Maintenance Until Progression in Myeloma PubMed | |
| Jun 23, 2022 | Nicole Foley | THROMBOSIS/BLEEDING DISORDERS Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A PubMed |
| Stefan Tarnawsky | Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data PubMed | |
| Jun 28, 2022 | David Russler-Germain | LYMPHOMA Ibrutinib Plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma PubMed |
| Zachary Crees | Axicabtagene Ciloleucel as First-Line Therapy in High-Risk Large B-Cell Lymphoma: The Phase 2 ZUMA-12 Trial PubMed |
| Date | Speaker | Title |
|---|---|---|
| Apr 7, 2021 | Alice Zhou | GASTROINTESTINAL CANCER Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma PubMed |
| Bindiya Patel | Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer PubMed | |
| Apr 21, 2021 | Miriam Jacobs | GENITOURINARY CANCERS Lenvatinib Plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma PubMed |
| Dhruv Bansal | Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma PubMed | |
| Apr 29, 2021 | Vanessa Eulo | BREAST CANCER Efficacy of Margetuximab Vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial PubMed |
| Gradon Nielsen | Pembrolizumab for Early Triple-Negative Breast Cancer PubMed | |
| May 6, 2021 | David Russler-Germain | MELANOMA Five-Year Analysis of Adjuvant Dabrafenib Plus Trametinib in Stage III Melanoma PubMed |
| Michael Kramer | Fecal Microbiota Transplant Promotes Response in Immunotherapy-Refractory Melanoma Patients PubMed | |
| May 13, 2021 | Raya Saba | BENIGN HEMATOLOGY / MYELOMA Long-Term Outcomes With Emicizumab Prophylaxis for Hemophilia A With or Without FVIII Inhibitors From the HAVEN 1-4 Studies PubMed |
| Zach Crees | Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma PubMed | |
| May 25, 2021 | Michael Slade | THROMBOSIS / BLEEDING DISORDERS Apixaban for the Treatment of Venous Thromboembolism Associated With Cancer PubMed |
| Fahrettin Covut | Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial PubMed | |
| Jun 2, 2021 | Lauren Shea | LYMPHOMA Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412 PubMed |
| Mary-Kate Malecek | Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma PubMed | |
| – – | ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma PubMed | |
| Jun 9, 2021 | Ryan Day | MYELOMA / LEUKEMIA Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission PubMed |
| Scott Goldsmith | Belantamab Mafodotin for Relapsed or Refractory Multiple Myeloma (DREAMM-2): A Two-Arm, Randomised, Open-Label, Phase 2 Study PubMed | |
| Jun 16, 2021 | Andrew Young | GYN ONC MALIGNANCIES A Single-Cell Landscape of High-Grade Serous Ovarian Cancer PubMed |
| Michael Iglesia | Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer PubMed | |
| Jun 24, 2021 | Whitney Hensing | LUNG CANCER First-Line Nivolumab Plus Ipilimumab Combined With Two Cycles of Chemotherapy in Patients With Non-Small-Cell Lung Cancer (CheckMate 9LA): An International, Randomised, Open-Label, Phase 3 Trial PubMed |
| – – | First-Line Nivolumab + Ipilimumab + Two Cycles of Chemotherapy Versus Chemotherapy Alone (4 Cycles) in Patients With Advanced Non-Small-Cell Lung Cancer: 2-Year Update From CheckMate 9LA view .ppt |
| Date | Speaker | Title |
|---|---|---|
| Jan 9, 2020 | Vanessa Eulo | BREAST CANCER [Tolaney S, et al. Cancer Res 2018; 78 (suppl): PD6-13] |
| Ramzi Abboud | Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer PubMed | |
| Jan 16, 2020 | Patrick Grierson | MELANOMA Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma PubMed |
| Ryan Day | Five-Year Outcomes With Dabrafenib Plus Trametinib in Metastatic Melanoma PubMed |
| Date | Speaker | Title |
|---|---|---|
| Nov 13, 2018 | Lauren Shea | LYMPHOMA Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety PubMed |
| Dec 11, 2018 | Amber Xu | BREAST CANCER Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer PubMed |
| Jan 10, 2019 | Mary-Kate Malecek | LOWER GI Duration of Adjuvant Chemotherapy for Stage III Colon Cancer PubMed |
| Bruna Pellini Ferreira | Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101 PubMed | |
| Feb 13, 2019 | Ramzi Abboud | UPPER GI Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study PubMed |
| Ramon Jin | Trifluridine/Tipiracil Versus Placebo in Patients With Heavily Pretreated Metastatic Gastric Cancer (TAGS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial PubMed | |
| Feb 14, 2019 | Vanessa Eulo | MPN A Phase 2 Study of Ruxolitinib in Combination With Azacitidine in Patients With Myelofibrosis PubMed |
| Ryan Day | Momelotinib Versus Best Available Therapy in Patients With Myelofibrosis Previously Treated With Ruxolitinib (SIMPLIFY 2): A Randomised, Open-Label, Phase 3 Trial PubMed | |
| Mar 20, 2019 | Aabha Oza | LUNG Pembrolizumab Plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer PubMed |
| Patrick Grierson | Pembrolizumab Plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer PubMed | |
| Apr 18, 2019 | Daniel Guy | HEME Apixaban to Prevent Venous Thromboembolism in Patients with Cancer PubMed |
| Amber Afzal | Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer PubMed | |
| Apr 25, 2019 | Scott Goldsmith | GENITOURINARY Pembrolizumab Plus Axitinib Versus Sunitinib for Advanced Renal-Cell Carcinoma PubMed |
| May 23, 2019 | Nkiruka Ezenwajiaku | MELANOMA Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF-Mutant Melanoma (COLUMBUS): A Multicentre, Open-Label, Randomised Phase 3 Trial PubMed |
| Gradon Nielsen | Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain PubMed | |
| Jun 13, 2019 | Brett Herzog | PRIMARY GLIOMAS Neoadjuvant Anti-PD-1 Immunotherapy Promotes a Survival Benefit With Intratumoral and Systemic Immune Responses in Recurrent Glioblastoma PubMed |
| Date | Speaker | Title |
|---|---|---|
| Aug 30, 2017 | Bita Fakhri | HODGKIN’S LYMPHOMA Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial PubMed |
| Eric Huselton | Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma PubMed | |
| Nancy Bartlett Faculty Discussant | Fine-Tuning the Treatment of Hodgkin’s Lymphoma PubMed | |
| Sep 27, 2017 | Natasha Edwin | ACUTE MYELOID LEUKEMIA Midostaurin Plus Chemotherapy for Acute Myeloid Leukemia With a FLT3 Mutation PubMed |
| Ramzi Abboud | Enasidenib in Mutant IDH2 Relapsed or Refractory Acute Myeloid Leukemia PubMed | |
| Geoff Uy Faculty Discussant | ||
| Oct 26, 2017 | Amber Xu | BREAST CANCER Olaparib for Metastatic Breast Cancer in Patients With a Germline BRCA Mutation PubMed |
| Aabha Oza | Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer PubMed | |
| Ashley Frith Faculty Discussant | ||
| Nov 29, 2017 | Amber Xu | LOWER GI Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer PubMed |
| Miriam Jacobs | Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer PubMed | |
| Haeseong Park Faculty Discussant | ||
| Dec 20, 2017 | Ramon Jin | UPPER GI Trastuzumab in Combination With Chemotherapy Versus Chemotherapy Alone for Treatment of HER2-Positive Advanced Gastric or Gastro-Oesophageal Junction Cancer (ToGA): A Phase 3, Open-Label, Randomised Controlled Trial PubMed |
| Amber Afzal | Regorafenib for Patients With Hepatocellular Carcinoma Who Progressed on Sorafenib Treatment (RESORCE): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial PubMed | |
| Andrea Wang-Gillam Faculty Discussant | ||
| Jan 24, 2018 | Daniel Guy | MPN/CML Ponatinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukaemia: An International, Randomised, Open-Label, Phase 3 Trial PubMed |
| Amber Afzal | JAK Inhibition With Ruxolitinib Versus Best Available Therapy for Myelofibrosis PubMed | |
| Amy Zhou Faculty Discussant | ||
| Feb 21, 2018 | Stephen Barman | LUNG Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer PubMed |
| Nkiruka Ezenwajiaku | Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer PubMed | |
| Sid Devarakonda Faculty Discussant | ||
| Mar 21, 2018 | Nkiruka Ezenwajiaku | GENITOURINARY Cabozantinib Versus Sunitinib as Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial PubMed |
| Patrick Grierson | Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma PubMed | |
| Joel Picus Faculty Discussant | ||
| Apr 18, 2018 | Nusayba Bagegni | BENIGN HEMATOLOGY Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura PubMed |
| Elaine Majerus Faculty Discussant | ||
| May 2, 2018 | Francesca Ferraro | HEMOPHILIA Emicizumab Prophylaxis in Hemophilia a With Inhibitors PubMed |
| Morey Blinder Faculty Discussant | ||
| May 3, 2018 | Pavan Bhamidipati | BENIGN HEMATOLOGY II Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism PubMed |
| Sana Saif Ur Rehman Faculty Discussant Kristen Sanfilippo Faculty Discussant | ||
| May 30, 2018 | Patrick Grierson | MELANOMA Adjuvant Dabrafenib Plus Trametinib in Stage III BRAF-Mutated Melanoma PubMed |
| Aabha Oza | Adjuvant Nivolumab Versus Ipilimumab in Resected Stage III or IV Melanoma PubMed | |
| George Ansstas Faculty Discussant | ||
| Jun 13, 2018 | Bruna Pellini Ferreira | PRIMARY GLIOMAS Interim Results From the CATNON Trial (EORTC Study 26053-22054) of Treatment With Concurrent and Adjuvant Temozolomide for 1p/19q Non-Co-Deleted Anaplastic Glioma: A Phase 3, Randomised, Open-Label Intergroup Study PubMed |
| Jian Campian Faculty Discussant | ||
| Jun 20, 2018 | Brett Herzog | BRAIN METASTASES Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer PubMed |
| Daniel Morgensztern Faculty Discussant |
| Date | Speaker | Title |
|---|---|---|
| Jul 26, 2016 | Ted Thomas | NON-SMALL-CELL LUNG CANCER Gefitinib Plus Chemotherapy Versus Placebo Plus Chemotherapy in EGFR-Mutation-Positive Non-Small-Cell Lung Cancer After Progression on First-Line Gefitinib (IMPRESS): A Phase 3 Randomised Trial PubMed |
| Sid Devarakonda | Afatinib Versus Gefitinib as First-Line Treatment of Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer (LUX-Lung 7): A Phase 2B, Open-Label, Randomised Controlled Trial PubMed | |
| Jeff Ward Faculty Discussant | ||
| Aug 24, 2016 | Bita Fakhri | ACUTE MYELOID LEUKEMIA Genomic Classification and Prognosis in Acute Myeloid Leukemia PubMed |
| Francesca Ferraro | Pre- and Post-Transplant Quantification of Measurable (‘Minimal’) Residual Disease via Multiparameter Flow Cytometry in Adult Acute Myeloid Leukemia PubMed | |
| Geoff Uy Faculty Discussant | ||
| Sep 28, 2016 | Andy Liao | BREAST CANCER Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials PubMed |
| Lingling Du | Adjuvant Ovarian Suppression in Premenopausal Breast Cancer PubMed | |
| Kathy Weilbaecher Faculty Discussant | ||
| Oct 26, 2016 | Patrick Grierson | LOWER GI Circulating Tumor DNA Analysis Detects Minimal Residual Disease and Predicts Recurrence in Patients With Stage II Colon Cancer PubMed |
| Stephen Barman | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency PubMed | |
| Kian-Huat Lim Faculty Discussant | ||
| Nov 23, 2016 | Nusayba Bagegni | UPPER GI Histopathological Regression After Neoadjuvant Docetaxel, Oxaliplatin, Fluorouracil, and Leucovorin Versus Epirubicin, Cisplatin, and Fluorouracil or Capecitabine in Patients With Resectable Gastric or Gastro-Oesophageal Junction Adenocarcinoma (FLOT4-AIO): Results From the Phase 2 Part of a Multicentre, Open-Label, Randomised Phase 2/3 Trial PubMed |
| Eric Huselton | Ramucirumab Plus Paclitaxel Versus Placebo Plus Paclitaxel in Patients With Previously Treated Advanced Gastric or Gastro-Oesophageal Junction Adenocarcinoma (RAINBOW): A Double-Blind, Randomised Phase 3 Trial PubMed | |
| Benjamin Tan Faculty Discussant | ||
| Dec 15, 2016 | Sana Saif Ur Rehman | MYELOPROLIFERATIVE NEOPLASMS Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial |
| Natasha Edwin | Cardiovascular events and intensity of treatment in polycythemia vera | |
| Steve Oh Faculty Discussant | ||
| Jan 25, 2017 | Eric Huselton | CHRONIC LYMPHOCYTIC LEUKEMIA Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia PubMed |
| Bita Fakhri | Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia PubMed | |
| Camille Abboud Faculty Discussant | ||
| Feb 22, 2017 | Natasha Edwin | THROMBOSIS/ANTICOAGULATION Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A PubMed |
| Aabha Oza | Recurrent Venous Thromboembolism and Abnormal Uterine Bleeding With Anticoagulant and Hormone Therapy Use PubMed | |
| Amy Zhou Faculty Discussant | ||
| Mar 22, 2017 | Stephen Barman | GENITOURINARY Long-Term Outcomes After Bladder-Preserving Tri-Modality Therapy for Patients With Muscle-Invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience PubMed |
| Tom Regenbogen | Quality of Life in Long-Term Survivors of Muscle-Invasive Bladder Cancer PubMed | |
| James Hsieh Faculty discussant Joel Picus Faculty Discussant | ||
| Apr 26, 2017 | Amber Xu | MELANOMA Combination of Dabrafenib Plus Trametinib for BRAF and MEK Inhibitor Pretreated Patients With Advanced BRAFV600-Mutant Melanoma: An Open-Label, Single Arm, Dual-Centre, Phase 2 Clinical Trial PubMed |
| Nkiruka Ezenwajiaku | Combined Nivolumab and Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Melanoma: 2-Year Overall Survival Outcomes in a Multicentre, Randomised, Controlled, Phase 2 Trial PubMed | |
| Jesse Keller Faculty Discussant | ||
| May 31, 2017 | Tanner Johanns | PRIMARY GLIOMAS Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy PubMed |
| Pavan Bhamidipati | Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma PubMed | |
| Jian Campian Faculty Discussant | ||
| Jun 21, 2017 | Pavan Bhamidipati | BRAIN METASTASES Alectinib Versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer PubMed |
| Amber Afzal | Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis PubMed | |
| Saiama Waqar Faculty Discussant |
| Date | Speaker | Title |
|---|---|---|
| Jul 21, 2015 | Ted Thomas | COLON CANCER Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer PubMed |
| Jesse Keller | High-Dose Chemoradiotherapy and Watchful Waiting for Distal Rectal Cancer: A Prospective Observational Study PubMed | |
| Kian H. Lim Faculty Discussant | ||
| Aug 26, 2015 | Stephen Barman | TRANSFUSION MEDICINE Hemolytic Events Associated With Intravenous Immune Globulin Therapy: A Qualitative Analysis of 263 Cases Reported to Four Manufacturers Between 2003 and 2012 PubMed |
| Sana Saif Ur Rehman | Combination of 4Ts Score and PF4/H-PaGIA for Diagnosis and Management of Heparin-Induced Thrombocytopenia: Prospective Cohort Study PubMed | |
| George Despotis Faculty Discussant | ||
| Sep 23, 2015 | Tom Regenbogen | HEAD AND NECK CANCER Comprehensive Genomic Characterization of Head and Neck Squamous Cell Carcinomas PubMed |
| Jeff Ward | Radiotherapy Plus Cetuximab for Locoregionally Advanced Head and Neck Cancer: 5-Year Survival Data From a Phase 3 Randomised Trial, and Relation Between Cetuximab-Induced Rash and Survival PubMed | |
| Doug Adkins Faculty Discussant | ||
| Oct 28, 2015 | Amy Zhou | ANTICOAGULATION Intracranial Hemorrhage in Patients With Brain Metastases Treated With Therapeutic Enoxaparin: A Matched Cohort Study PubMed |
| Natasha Edwin | Low-Molecular-Weight Heparin Versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients With Cancer PubMed | |
| Elaine Majerus Faculty Discussant | ||
| Nov 17, 2015 | Andy Liao | BREAST CANCER The Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib in Combination With Letrozole Versus Letrozole Alone as First-Line Treatment of Oestrogen Receptor-Positive, HER2-Negative, Advanced Breast Cancer (PALOMA-1/TRIO-18): A Randomised Phase 2 Study PubMed |
| Tom Regenbogen | Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer PubMed | |
| Katherine Weilbaecher Faculty Discussant | ||
| Dec 11, 2015 | Bita Fakhri | LYMPHOMA Lenalidomide Plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma PubMed |
| Peter Riedell | Noninvasive Monitoring of Diffuse Large B-Cell Lymphoma by Immunoglobulin High-Throughput Sequencing PubMed | |
| Brad Kahl Faculty Discussant | ||
| Jan 27, 2016 | Sid Devarakonda | LUNG CANCER Comprehensive Molecular Profiling of Lung Adenocarcinoma PubMed |
| Lingling Du | Nivolumab Versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer PubMed | |
| Daniel Morgensztern Faculty Discussant | ||
| Feb 24, 2016 | Andrea Teague | NON-COLON GI CANCER Preoperative chemoradiotherapy for esophageal or junctional cancer PubMed |
| Brian Hess | Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer PubMed | |
| Craig Lockhart Faculty Discussant | ||
| Mar 18, 2016 | Lingling Du | PROSTATE CANCER Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial PubMed |
| Jesse Keller | DNA-repair defects and olaparib in metastatic prostate cancer PubMed | |
| Bruce Roth Faculty Discussant | ||
| Apr 27, 2016 | Pavan Bhamidipati | HEMOPHILIAS Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial PubMed |
| Nusayba Bagegni | Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A PubMed | |
| Elaine Majerus Faculty Discussant | ||
| May 25, 2016 | Tanner Johanns | NEURO-ONCOLOGY NovoTTF-100A Versus Physician’s Choice Chemotherapy in Recurrent Glioblastoma: A Randomised Phase III Trial of a Novel Treatment Modality PubMed |
| Ted Thomas | Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial PubMed | |
| Milan Chheda Faculty Discussant | ||
| Jun 22, 2016 | Armin Rashidi | ACUTE LEUKEMIA/TRANSPLANT Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission? PubMed |
| Eric Huselton | Assessment of Minimal Residual Disease in Standard-Risk AML PubMed | |
| Mark Schroeder Faculty Discussant |
| Date | Speaker | Title |
|---|---|---|
| Jul 9, 2014 | Jesse Keller | HEAD AND NECK CANCER Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer PubMed |
| Jeff Ward | Induction Chemotherapy Plus Radiation Compared with Surgery Plus Radiation in Patients with Advanced Laryngeal Cancer PubMed | |
| Douglas Adkins Faculty Discussant | ||
| Aug 27, 2014 | Brian Hess | TRANSFUSION MEDICINE Transfusion-Related Adverse Events in the Platelet Dose Study PubMed |
| Armin Rashidi | Impact of Donor-Recipient Major ABO Mismatch on Allogeneic Transplantation Outcome According to Stem Cell Source PubMed | |
| Brenda Grossman Faculty Discussant | ||
| Sep 24, 2014 | Jeff Ward | COLON CANCER Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer PubMed |
| Kevin Chen | Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07 PubMed | |
| Kian Lim Faculty Discussant | ||
| Oct 22, 2014 | Andrea Teague | THROMBOSIS Direct Oral Anticoagulants Compared With Vitamin K Antagonists for Acute Venous Thromboembolism: Evidence From Phase 3 Trials PubMed |
| Ted Thomas | Long-Term Outcome After Additional Catheter-Directed Thrombolysis Versus Standard Treatment for Acute Iliofemoral Deep Vein Thrombosis (the CaVenT Study): A Randomised Controlled Trial PubMed | |
| Elaine Majerus Faculty Discussant | ||
| Nov 25, 2014 | Andy Liao | BREAST CANCER Pertuzumab Plus Trastuzumab in Combination With Standard Neoadjuvant Anthracycline-Containing and Anthracycline-Free Chemotherapy Regimens in Patients With HER2-Positive Early Breast Cancer: A Randomized Phase II Cardiac Safety Study (TRYPHAENA) PubMed |
| Jesse Keller | Efficacy and Safety of Neoadjuvant Pertuzumab and Trastuzumab in Women With Locally Advanced, Inflammatory, or Early HER2-Positive Breast Cancer (NeoSphere): A Randomised Multicentre, Open-Label, Phase 2 Trial PubMed | |
| Michael Naughton Faculty Discussant | ||
| Dec 18, 2014 | Armin Rashidi | CHRONIC LYMPHOCYTIC LEUKEMIA Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia PubMed |
| Tanner Johanns | Addition of Rituximab to Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukaemia: A Randomised, Open-Label, Phase 3 Trial PubMed | |
| Mark Schroeder Faculty Discussant | ||
| Jan 28, 2015 | Kevin Chen | LUNG CANCER Use of Thoracic Radiotherapy for Extensive Stage Small-Cell Lung Cancer: A Phase 3 Randomised Controlled Trial PubMed |
| Ashley Frith | Weekly Nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Final Results of a Phase III Trial PubMed | |
| Daniel Morgensztern Faculty Discussant | ||
| Feb 19, 2015 | Peter Riedell | HODGKIN LYMPHOMA Brentuximab Vedotin Combined With ABVD or AVD for Patients With Newly Diagnosed Hodgkin’s Lymphoma: A Phase 1, Open-Label, Dose-Escalation Study PubMed |
| Amy Zhou | Omitting Radiotherapy in Early Positron Emission Tomography-Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial PubMed | |
| Nina Wagner-Johnston Faculty Discussant | ||
| Mar 19, 2015 | Rusudan Hopman | PROSTATE CANCER Duration of Androgen Suppression in the Treatment of Prostate Cancer PubMed |
| Tom Regenbogen | Enzalutamide in Metastatic Prostate Cancer Before Chemotherapy PubMed | |
| Vivek Arora Faculty Discussant | ||
| Apr 22, 2015 | Brian Hess | HEMOPHILIAS Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B PubMed |
| Elaine Majerus Faculty Discussant | ||
| May 27, 2015 | Lingling Du | NEURO-ONCOLOGY Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial PubMed |
| Sid Devarakonda | Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802 PubMed | |
| Jian Campian Faculty Discussant | ||
| Jun 24, 2015 | Terrence Wong | ACUTE LEUKEMIA/TRANSPLANT Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia PubMed |
| Matt Christopher | Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia PubMed | |
| Geoff Uy Faculty Discussant Ravi Vij Faculty Discussant |